Esophageal Protection Study: A Multicenter Study

About the trial

Sponsor

Advanced Cooling Therapy LLC, d/b/a Attune Medical (with University of Pennsylvania, Berry Consultants, Texas Cardiac Arrhythmia Research Foundation, Beth Israel Deaconess Medical Center, Kansas City Cardiac Arrhythmia Research LLC)

Tested

ensoETM. Esophageal cooling during AF ablation (device), Esophageal temperature monitoring probe (device)

Dates

Started 2022-03-10; completion 2026-05-15

Results posted

Not yet

Atrial fibrillation (AF) is a common debilitating heart rhythm condition that can cause heart failure and negatively impact a patient's outlook in terms of symptoms and disability. It is an irregular fast heart rhythm disorder coming from the top chamber of the heart (left atrium). Catheter ablation treatment has been shown to be effective in controlling or eliminating AF and its associated symptoms. This is now a common and effective treatment option for patients suffering with AF. During ablation, thermal energy is applied in the top chamber of the heart (the left atrium) to abolish abnormal electrical signals that cause AF. It is generally a safe procedure, but one potential risk assoc…

From ClinicalTrials.gov, last updated 2026-07-08. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Haemonetics Corporation reported $33,929 in research payments for this study in 2025 (13 payments).

Products named: Ensoetm, Blanketrol

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.